Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2026-02-02 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from Ognian Donev under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000002262
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically Ognian Donev, an Executive Director of 'Sopharma' AD. It follows the standard template required by Article 19 of Regulation (EU) No 596/2014 (Market Abuse Regulation) for reporting insider transactions. Since it details a specific transaction by an insider, it falls under the 'Director's Dealing' category.
2026-02-02 English
Notification from Ognian Donev under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000001264
Director's Dealing Classification · 100% confidence The document is a standard template for reporting transactions by persons discharging managerial responsibilities (PDMRs) under the EU Market Abuse Regulation (MAR). It explicitly identifies Ognian Donev, an Executive Director of Sopharma AD, as the person discharging managerial responsibilities and details the exercise of rights/warrants. This falls directly under the category of Director's Dealing.
2026-02-02 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a formal notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the percentage of share capital, the total value, and the average price per share, while also updating the total number of treasury shares held by the company. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2026-01-30 English
Preliminary annual individual financial report for 2025
Regulatory Filings
2026-01-30 Polish
Notification from "Telso" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000003260
Director's Dealing Classification · 100% confidence The document is a notification of insider transactions by a person discharging managerial responsibilities under Regulation 596/2014. It details the name of the insider, the issuer, the financial instrument involved, the nature of the transaction, price, volume, date, and place of the transaction. This type of document corresponds to a report of personal share transactions by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document is not an annual report, earnings release, or any other financial report but a regulatory notification of insider dealings.
2026-01-29 Polish
Notification from "Telso" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000002262
Director's Dealing Classification · 95% confidence The document contains detailed information about a person discharging managerial responsibilities, including their name, position, and details of transactions involving financial instruments. It references regulatory provisions (Regulation 596/2014) related to managerial responsibilities and disclosures. The content focuses on reporting personal transactions by a company director or executive, specifically the exercise of rights for issue warrants. There is no indication of financial results, company performance, or meeting materials. This matches the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length and detail support this classification with high confidence.
2026-01-29 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.